Cargando…

Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer’s Dementia Are Frequently Below the Recommended Levels

BACKGROUND: Acetylcholinesterase inhibitors (AChE-I) are recommended for the treatment of cognitive symptoms but also of behavioral and psychological symptoms in dementia. They are widely used not only in Alzheimer's disease, but also in other forms of dementia. Efficacy of treatment might depe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortner, Marion, Stange, Marion, Schneider, Heike, Schroeder, Charlotte, Buerger, Katharina, Müller, Claudia, Dorn, Bianca, Goldhardt, Oliver, Diehl-Schmid, Janine, Förstl, Hans, Steimer, Werner, Grimmer, Timo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253642/ https://www.ncbi.nlm.nih.gov/pubmed/32508640 http://dx.doi.org/10.3389/fphar.2020.00691

Ejemplares similares

Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil
por: Ortner, Marion, et al.
Publicado: (2020)

Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
por: Ortner, Marion, et al.
Publicado: (2020)

Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
por: Ortner, Marion, et al.
Publicado: (2019)

Cerebrospinal fluid lactate levels along the Alzheimer’s disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers
por: Zebhauser, Paul Theo, et al.
Publicado: (2022)

Regional Cerebral Associations Between Psychometric Tests and Imaging Biomarkers in Alzheimer’s Disease
por: Hedderich, Dennis M., et al.
Publicado: (2020)

The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort
por: Amft, Michaela, et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers for Alzheimer’s disease: the role of apolipoprotein E genotype, age, and sex
por: Mehrabian, Shima, et al.
Publicado: (2015)

Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer’s Disease Regardless of Concomitant Small Vessel Disease
por: Ortner, Marion, et al.
Publicado: (2023)

Decreased Vascular Pulsatility in Alzheimer’s Disease Dementia Measured by Transcranial Color-Coded Duplex Sonography
por: Ortner, Marion, et al.
Publicado: (2019)

Progressively Disrupted Intrinsic Functional Connectivity of Basolateral Amygdala in Very Early Alzheimer’s Disease
por: Ortner, Marion, et al.
Publicado: (2016)

Altered neurovascular coupling as measured by optical imaging: a biomarker for Alzheimer’s disease
por: Kotliar, Konstantin, et al.
Publicado: (2017)

Suicidal Ideations and Behavior in Patients With Young and Late Onset Dementia
por: Ortner, Marion, et al.
Publicado: (2021)

Correction: (18)F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases
por: Grimmer, Timo, et al.
Publicado: (2018)

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET
por: Goldhardt, Oliver, et al.
Publicado: (2019)

Development and testing of an informative guide about palliative care for family caregivers of people with advanced dementia
por: Riedl, Lina, et al.
Publicado: (2020)

LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's disease in humans in-vivo
por: Grimmer, Timo, et al.
Publicado: (2014)

Economics: the view from below
por: Fourcade, Marion
Publicado: (2018)

Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia
por: Hoffmann, Falk, et al.
Publicado: (2011)

Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer’s disease
por: Myers, Nicholas, et al.
Publicado: (2014)

Frontotemporal lobar degeneration: current perspectives
por: Riedl, Lina, et al.
Publicado: (2014)

Step by Step: Kinematics of the Reciprocal Trail Making Task Predict Slowness of Activities of Daily Living Performance in Alzheimer’s Disease
por: Gulde, Philipp, et al.
Publicado: (2018)

An Explorative Note on Apraxia Tests
por: Gulde, Philipp, et al.
Publicado: (2018)

A case report of cholinesterase inhibitor poisoning: cholinesterase activities and analytical methods for diagnosis and clinical decision making
por: Amend, N., et al.
Publicado: (2020)

FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations
por: Diehl-Schmid, Janine, et al.
Publicado: (2019)

Cholinesterase Research
por: Korabecny, Jan, et al.
Publicado: (2021)

Disease specific and nonspecific metabolic brain networks in behavioral variant of frontotemporal dementia
por: Rus, Tomaž, et al.
Publicado: (2022)

IssuEs in Palliative care for people in advanced and terminal stages of Young-onset and Late-Onset dementia in GErmany (EPYLOGE): the study protocol
por: Diehl-Schmid, Janine, et al.
Publicado: (2018)

Neuronavigated repetitive transcranial magnetic stimulation as novel mapping technique provides insights into language function in primary progressive aphasia
por: Mueller-Sarnowski, Felix, et al.
Publicado: (2021)

A multivariate metabolic imaging marker for behavioral variant frontotemporal dementia
por: Nazem, Amir, et al.
Publicado: (2018)

An augmented reality approach for ADL support in Alzheimer’s disease: a crossover trial
por: Rohrbach, Nina, et al.
Publicado: (2019)

Endochondral Ossification Is Accelerated in Cholinesterase-Deficient Mice and in Avian Mesenchymal Micromass Cultures
por: Spieker, Janine, et al.
Publicado: (2017)

Methylmercury-cholinesterase interactions in rats.
por: Hastings, F L, et al.
Publicado: (1975)

Cholinesterase inhibitors from botanicals
por: Ahmed, Faiyaz, et al.
Publicado: (2013)

Cholinesterase inhibitors as Alzheimer's therapeutics
por: Sharma, Kamlesh
Publicado: (2019)

Cholinesterases in Tripartite Neuromuscular Synapse
por: Petrov, Konstantin A., et al.
Publicado: (2021)

Cholinesterase inhibitors for the treatment of dementia: real-life data in Hungary
por: Balázs, Nóra, et al.
Publicado: (2021)

Cholinesterase Research Outreach Project (CROP): measuring cholinesterase activity and pesticide use in an agricultural community
por: Cotton, Jacqueline, et al.
Publicado: (2015)

Cholinesterase research outreach project (CROP): point of care cholinesterase measurement in an Australian agricultural community
por: Cotton, Jacqueline, et al.
Publicado: (2018)

How Do Persons with Young and Late Onset Dementia Die?
por: Roβmeier, Carola, et al.
Publicado: (2021)

The significance of thymoquinone administration on liver toxicity of diazinon and cholinesterase activity; a recommendation for prophylaxis among individuals at risk
por: Danaei, Gholam-Hassan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_62799md0bu5n6bae5he7d0jpu5